Alighieri, D. La Divina Commedia - I. Inferno Canto XXIX (1307–1321).

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 51, 237–267 (2009).

Google Scholar 

Kremer, A. E., Beuers, U., Oude-Elferink, R. P. & Pusl, T. Pathogenesis and treatment of pruritus in cholestasis. Drugs 68, 2163–2182 (2008).

CAS  PubMed  Google Scholar 

Bergasa, N. V. The itch of liver disease. Semin. Cutan. Med. Surg. 30, 93–98 (2011).

CAS  PubMed  Google Scholar 

Beuers, U., Kremer, A. E., Bolier, R. & Elferink, R. P. Pruritus in cholestasis: facts and fiction. Hepatology 60, 399–407 (2014).

CAS  PubMed  Google Scholar 

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J. Hepatol. 67, 145–172 (2017).

Google Scholar 

Mayo, M. J. et al. Impact of pruritus on quality of life and current treatment patterns in patients with primary biliary cholangitis. Dig. Dis. Sci. https://doi.org/10.1007/s10620-022-07581-x (2022).

Article  PubMed  Google Scholar 

van Munster, K. N., Dijkgraaf, M. G. W., Oude Elferink, R. P. J., Beuers, U. & Ponsioen, C. Y. Symptom patterns in the daily life of PSC patients. Liver Int. 42, 1562–1570 (2022).

PubMed  PubMed Central  Google Scholar 

Kenyon, A. P. et al. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet. Med. 3, 25–29 (2010).

CAS  PubMed  PubMed Central  Google Scholar 

McPhedran, N. T. & Henderson, R. D. Pruritus and Jaundice. Can. Med. Assoc. J. 92, 1258–1260 (1965).

CAS  PubMed  PubMed Central  Google Scholar 

Loomba, R. et al. Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH. Hepatology 73, 625–643 (2021).

CAS  PubMed  Google Scholar 

Langedijk, J., Beuers, U. H. & Oude Elferink, R. P. J. Cholestasis-associated pruritus and its pruritogens. Front. Med. 8, 639674 (2021).

Google Scholar 

Kremer, A. E., Feramisco, J., Reeh, P. W., Beuers, U. & Oude Elferink, R. P. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochim. Biophys. Acta 1842, 869–892 (2014).

CAS  PubMed  Google Scholar 

Perino, A., Demagny, H., Velazquez-Villegas, L. & Schoonjans, K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol. Rev. 101, 683–731 (2021).

CAS  PubMed  Google Scholar 

Fiorucci, S. & Distrutti, E. The pharmacology of bile acids and their receptors. Handb. Exp. Pharmacol. 256, 3–18 (2019).

CAS  PubMed  Google Scholar 

Kremer, A. E. et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 139, 1008–1018 (2010).

CAS  PubMed  Google Scholar 

Ghent, C. N., Bloomer, J. R. & Klatskin, G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus. Gastroenterology 73, 1125–1130 (1977).

CAS  PubMed  Google Scholar 

Alemi, F. et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J. Clin. Invest. 123, 1513–1530 (2013).

CAS  PubMed  PubMed Central  Google Scholar 

Yu, H. et al. MRGPRX4 is a bile acid receptor for human cholestatic itch. eLife 8, e48431 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

de Vries, E. et al. Fibrates for Itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, Placebo-controlled trial. Gastroenterology 160, 734–743 (2021).

PubMed  Google Scholar 

Beuers, U. et al. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 15, 603–608 (1992).

CAS  PubMed  Google Scholar 

Cole, S. P. et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650–1654 (1992).

CAS  PubMed  Google Scholar 

Meixiong, J., Vasavda, C., Snyder, S. H. & Dong, X. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus. Proc. Natl Acad. Sci. USA 116, 10525–10530 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

Harms, M. H. et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J. Hepatol. 71, 357–365 (2019).

CAS  PubMed  Google Scholar 

Hempfling, W., Dilger, K. & Beuers, U. Systematic review: ursodeoxycholic acid — adverse effects and drug interactions. Aliment. Pharmacol. Ther. 18, 963–972 (2003).

CAS  PubMed  Google Scholar 

Dilger, K. et al. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health. J. Hepatol. 57, 133–140 (2012).

CAS  PubMed  Google Scholar 

Langedijk, J. et al. Reduced spontaneous itch in mouse models of cholestasis. Sci. Rep. 11, 6127 (2021).

PubMed  PubMed Central  Google Scholar 

Cipriani, S. et al. Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signaling. PLoS ONE 10, e0129866 (2015).

PubMed  PubMed Central  Google Scholar 

Lieu, T. et al. The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. Gastroenterology 147, 1417–1428 (2014).

CAS  PubMed  Google Scholar 

Ostadhadi, S. et al. Evidence for the involvement of nitric oxide in cholestasis-induced itch associated response in mice. Biomed. Pharmacother. 84, 1367–1374 (2016).

CAS  PubMed  Google Scholar 

Boyer, J. L. Bile formation and secretion. Compr. Physiol. 3, 1035–1078 (2013).

PubMed  PubMed Central  Google Scholar 

Nevens, F. et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N. Engl. J. Med. 375, 631–643 (2016).

CAS  PubMed  Google Scholar 

Shah, R. A. & Kowdley, K. V. Obeticholic acid for the treatment of nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 14, 311–321 (2020).

CAS  PubMed  Google Scholar 

Neuschwander-Tetri, B. A. et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385, 956–965 (2015).

CAS  PubMed  Google Scholar 

Fiorucci, S. et al. Targeting FXR in cholestasis: hype or hope. Expert Opin. Ther. Targets 18, 1449–1459 (2014).

CAS  PubMed  Google Scholar 

Trauner, M. et al. The nonsteroidal farnesoid X receptor agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis. Hepatology 70, 788–801 (2019).

CAS  PubMed  Google Scholar 

Gege, C., Hambruch, E., Hambruch, N., Kinzel, O. & Kremoser, C. Nonsteroidal FXR ligands: current status and clinical applications. Handb. Exp. Pharmacol. 256, 167–205 (2019).

CAS  PubMed  Google Scholar 

Kremoser, C. FXR agonists for NASH: How are they different and what difference do they make? J. Hepatol. 75, 12–15 (2021).

PubMed  Google Scholar 

Erken, R. et al. Farnesoid X receptor agonist for the treatment of chronic hepatitis B: a safety study. J. Viral Hepat. https://doi.org/10.1111/jvh.13608 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Kuiper, E. M. et al. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology 52, 1334–1340 (2010).

CAS  PubMed  Google Scholar 

Vaz, F. M. et al. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype. Hepatology 61, 260–267 (2015).

CAS  PubMed  Google Scholar 

Van Herpe, F. et al. NTCP deficiency and persistently raised bile salts: an adult case. J. Inherit. Metab. Dis. 40, 313–315 (2017).

PubMed  Google Scholar 

Dong, C. et al. Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients. Medicine 98, e17305 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

Zou, T. T., Zhu, Y., Wan, C. M. & Liao, Q. Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review. Transl. Pediatr. 10, 1045–1054 (2021).

PubMed  PubMed Central  Google Scholar 

Erlinger, S. NTCP deficiency: a new inherited disease of bile acid transport. Clin. Res. Hepatol. Gastroenterol. 39, 7–8 (2015).

PubMed  Google Scholar 

Meixiong, J. et al. Identification of a bilirubin receptor that may mediate a component of cholestatic itch. eLlife https://doi.org/10.7554/eLife.44116 (2019).

Article  Google Scholar 

Stapelbroek, J. M., van Erpecum, K. J., Klomp, L. W. & Houwen, R. H. Liver disease associated with canalicular transport defects: current and future therapies. J. Hepatol. 52, 258–271 (2010).

CAS  PubMed  Google Sc